Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;98:301-302
doi: 10.1161/01.RES.0000208057.36708.48
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barth, A. S.
Right arrow Articles by Kääb, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barth, A. S.
Right arrow Articles by Kääb, S.
Related Collections
Right arrowRelated Article
(Circulation Research. 2006;98:301.)
© 2006 American Heart Association, Inc.


Editorials

MAPK = Mitogen-Activated Protein KChIP2?

Unraveling Signaling Pathways Controlling Cardiac Ito Expression

Andreas S. Barth, Stefan Kääb

From the Department of Medicine I (A.S.B., S.K.), University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany; and the Department of Cardiology (A.S.B.), Johns Hopkins University, Baltimore, Md.

Correspondence to Stefan Kääb, MD, Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-University, 81366 Munich, Germany. E-mail Stefan.Kaab@med.uni-muenchen.de



See related article, pages 386–393


Key Words: MAP Kinases • signal transduction • transient outward current • auxiliary subunit


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Reduction in density of the cardiac calcium-independent transient outward potassium current (Ito1) is one of the most consistent findings in electrophysiological remodeling observed in animal models of left ventricular hypertrophy and failure as well as in the human heart under pathological conditions.1 Initially attributed to downregulation of the mRNA of pore-forming Kv4 subunits,2 a more complex picture emerged over time as several auxiliary subunits were identified, offering new potential regulatory elements for controlling Ito1 density. KChIP2 is a dazzling member of this group of beta-subunits which assembles with pore-forming Kv4 subunits in 4:4 complexes to produce native Ito1 channels.3 Several different KChIP2 splice variants are expressed in the human heart and the major KChIP2 isoform (KChIP2c) has been found to boost Ito1 current density and to speed up recovery from inactivation, thereby recapitulating several, albeit not all, features of native Ito1 channels.4 Importantly, myocytes isolated from KChIP2 knock-out mice exhibited a complete, selective loss of Ito1, whereas an {approx}50% reduction was observed in cardiomyocytes from heterozygous animals, indicating that KChIP2 can quantitatively regulate Ito1.5 In line with this finding, KChIP2 mRNA typically distributes across the myocardial wall in a fashion paralleling the gradient of the transient outward current with fast recovery from inactivation encoded by Kv4 channels, with largest concentrations in subepicardium (EPI) and smallest in subendocardium (ENDO) in human and canine hearts.6 This suggests that KChIP2 is the limiting factor in cell surface expression of Ito1 channels, rather than the pore-forming Kv4 subunits which are . . . [Full Text of this Article]


Related Article:

Mitogen-Activated Protein Kinases Control Cardiac KChIP2 Gene Expression
Ying Jia and Koichi Takimoto
Circ. Res. 2006 98: 386-393. [Abstract] [Full Text] [PDF]